Literature DB >> 21325265

Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.

Wei Wu1, Ankur V Dnyanmote, Sanjay K Nigam.   

Abstract

Recent data from knockouts, human disease, and transport studies suggest that solute carrier (SLC) and ATP binding cassette (ABC) multispecific "drug" transporters maintain effective organ and body fluid concentrations of key nutrients, signaling molecules, and antioxidants. These processes involve transcellular movement of solutes across epithelial barriers and fluid compartments (e.g., blood, cerebrospinal fluid, urine, bile) via "matching" or homologous sets of SLC (e.g., SLC21, SLC22, SLC47) and ABC transporters. As described in the "Remote Sensing and Signaling Hypothesis" (Biochem Biophys Res Commun 323:429-436, 2004; Biochem Biophys Res Commun 351:872-876, 2006; J Biol Chem 282:23841-23853, 2007; Nat Clin Pract Nephrol 3:443-448, 2007; Mol Pharmacol 76:481-490, 2009), highly regulated transporter networks with overlapping substrate preferences are involved in sensing and signaling to maintain homeostasis in response to environmental changes (e.g., substrate imbalance and injury). They function in parallel with (and interact with) the endocrine and autonomic systems. Uric acid (urate), carnitine, prostaglandins, conjugated sex steroids, cGMP, odorants, and enterobiome metabolites are discussed here as examples. Xenobiotics hitchhike on endogenous carrier systems, sometimes leading to toxicity and side effects. By regulation of the expression and/or function of various remote organ multispecific transporters after injury, the overall transport capacity of the remote organ to handle endogenous toxins, metabolites, and signaling molecules may change, aiding in recovery. Moreover, these transporters may play a role in communication between organisms. The specific cellular components involved in sensing and altering transporter abundance or functionality depend upon the metabolite in question and probably involve different types of sensors as well as epigenetic regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325265      PMCID: PMC3082935          DOI: 10.1124/mol.110.070607

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  77 in total

Review 1.  Medical implications of hyperuricemia.

Authors:  Larissa Sachs; Kerri L Batra; Bernard Zimmermann
Journal:  Med Health R I       Date:  2009-11

2.  A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubules.

Authors:  Katsuko Shiraya; Taku Hirata; Ryo Hatano; Shushi Nagamori; Pattama Wiriyasermkul; Promsuk Jutabha; Mitsunobu Matsubara; Shigeaki Muto; Hidekazu Tanaka; Shinji Asano; Naohiko Anzai; Hitoshi Endou; Akira Yamada; Hiroyuki Sakurai; Yoshikatsu Kanai
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

Review 3.  A 'complexity' of urate transporters.

Authors:  Alan F Wright; Igor Rudan; Nicholas D Hastie; Harry Campbell
Journal:  Kidney Int       Date:  2010-07-07       Impact factor: 10.612

Review 4.  Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier.

Authors:  David S Miller
Journal:  Trends Pharmacol Sci       Date:  2010-04-24       Impact factor: 14.819

Review 5.  Non-phenolic radical-trapping antioxidants.

Authors:  Mario C Foti; Riccardo Amorati
Journal:  J Pharm Pharmacol       Date:  2009-11       Impact factor: 3.765

Review 6.  Short-term regulation of organic anion transporters.

Authors:  Peng Duan; Guofeng You
Journal:  Pharmacol Ther       Date:  2009-09-08       Impact factor: 12.310

7.  The evolutionary fate of the genes encoding the purine catabolic enzymes in hominoids, birds, and reptiles.

Authors:  Alaine C Keebaugh; James W Thomas
Journal:  Mol Biol Evol       Date:  2010-01-27       Impact factor: 16.240

Review 8.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

9.  Simiao pill ameliorates urate underexcretion and renal dysfunction in hyperuricemic mice.

Authors:  Qing-Hua Hu; Rui-Qing Jiao; Xing Wang; Yao-Zhong Lv; Ling-Dong Kong
Journal:  J Ethnopharmacol       Date:  2010-02-26       Impact factor: 4.360

10.  Representation and transformation of sensory information in the mouse accessory olfactory system.

Authors:  Julian P Meeks; Hannah A Arnson; Timothy E Holy
Journal:  Nat Neurosci       Date:  2010-05-09       Impact factor: 24.884

View more
  54 in total

Review 1.  Transport in technicolor: mapping ATP-binding cassette transporters in sea urchin embryos.

Authors:  Tufan Gökirmak; Lauren E Shipp; Joseph P Campanale; Sascha C T Nicklisch; Amro Hamdoun
Journal:  Mol Reprod Dev       Date:  2014-08-22       Impact factor: 2.609

2.  Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney.

Authors:  Derina E Sweeney; Volker Vallon; Timo Rieg; Wei Wu; Thomas F Gallegos; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2011-04-14       Impact factor: 4.436

3.  Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis.

Authors:  Sun-Young Ahn; Neema Jamshidi; Monica L Mo; Wei Wu; Satish A Eraly; Ankur Dnyanmote; Kevin T Bush; Tom F Gallegos; Douglas H Sweet; Bernhard Ø Palsson; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

4.  Obesity treatment by epigallocatechin-3-gallate-regulated bile acid signaling and its enriched Akkermansia muciniphila.

Authors:  Lili Sheng; Prasant Kumar Jena; Hui-Xin Liu; Ying Hu; Nidhi Nagar; Denise N Bronner; Matthew L Settles; Andreas J Bäumler; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-06-08       Impact factor: 5.191

Review 5.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

Review 6.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

Review 7.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

8.  In vitro models of molecular and nano-particle transport across the blood-brain barrier.

Authors:  Cynthia Hajal; Marco Campisi; Clara Mattu; Valeria Chiono; Roger D Kamm
Journal:  Biomicrofluidics       Date:  2018-05-31       Impact factor: 2.800

Review 9.  The systems biology of uric acid transporters: the role of remote sensing and signaling.

Authors:  Sanjay K Nigam; Vibha Bhatnagar
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-07       Impact factor: 2.894

Review 10.  Expression and function of renal and hepatic organic anion transporters in extrahepatic cholestasis.

Authors:  Anabel Brandoni; María Herminia Hazelhoff; Romina Paula Bulacio; Adriana Mónica Torres
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.